HPRT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
2.47190000002284E-06 |
Normal-vs-Stage3 |
2.22044604925031E-16 |
Normal-vs-Stage4 |
3.27240001762874E-09 |
Stage1-vs-Stage2 |
2.027600E-01 |
Stage1-vs-Stage3 |
5.852000E-01 |
Stage1-vs-Stage4 |
3.880400E-01 |
Stage2-vs-Stage3 |
1.429560E-01 |
Stage2-vs-Stage4 |
6.439400E-01 |
Stage3-vs-Stage4 |
2.677600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62470037423645E-12 |
Normal-vs-AfricanAmerican |
6.73329947353807E-10 |
Normal-vs-Asian |
8.43769498715119E-15 |
Caucasian-vs-AfricanAmerican |
4.684000E-01 |
Caucasian-vs-Asian |
4.818100E-03 |
AfricanAmerican-vs-Asian |
8.279900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
4.915400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.41339994842139E-09 |
Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
Normal-vs-Age(81-100Yrs) |
1.05260000005103E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.215000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.686000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.296000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.469200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.826200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.24639973289698E-10 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
2.43719999959424E-07 |
Grade 1-vs-Grade 2 |
2.241200E-01 |
Grade 1-vs-Grade 3 |
8.638000E-01 |
Grade 1-vs-Grade 4 |
6.171700E-02 |
Grade 2-vs-Grade 3 |
5.634400E-02 |
Grade 2-vs-Grade 4 |
2.362000E-01 |
Grade 3-vs-Grade 4 |
3.138000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
1.58439994457638E-09 |
ccA subtype-vs-ccB subtype |
3.12559999993134E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62803104331033E-12 |
Normal-vs-N1 |
2.34579999999207E-05 |
N0-vs-N1 |
7.395000E-01 |
|
|